Vietnam Medical and Pharmaceutical Investment JSC (HOSE:JVC)
4,970.00
-130.00 (-2.55%)
At close: Mar 6, 2026
HOSE:JVC Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2017 | FY 2016 | 2015 - 2012 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Mar '17 Mar 31, 2017 | Mar '16 Mar 31, 2016 | 2015 - 2012 |
| Net Income | 49,597 | 40,282 | 52,634 | -31,694 | -1,335,782 | Upgrade
|
| Depreciation & Amortization | 24,444 | 34,549 | 47,454 | 69,644 | 75,241 | Upgrade
|
| Other Amortization | 298.19 | 753.55 | - | 20.74 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -11,284 | -24,512 | -25,989 | 8,931 | 28,695 | Upgrade
|
| Other Operating Activities | 4,624 | 21,125 | 6,063 | -7,186 | 1,282,007 | Upgrade
|
| Change in Accounts Receivable | -202,768 | 65,610 | -60,209 | -36,210 | -401,396 | Upgrade
|
| Change in Inventory | 30,256 | -95,953 | 5,541 | 108,869 | 46,589 | Upgrade
|
| Change in Accounts Payable | -4,149 | 47,233 | -30,881 | -31,325 | -3,710 | Upgrade
|
| Change in Other Net Operating Assets | 1,244 | -3,333 | -1,088 | -4,922 | -10,667 | Upgrade
|
| Operating Cash Flow | -107,738 | 85,753 | -6,474 | 76,126 | -319,023 | Upgrade
|
| Capital Expenditures | -260,621 | -16,594 | -43,363 | -42,587 | -8,810 | Upgrade
|
| Sale of Property, Plant & Equipment | 4,211 | 3,939 | 14,049 | 3,044 | 2,245 | Upgrade
|
| Investment in Securities | -52,800 | -140,000 | - | 752 | 183,848 | Upgrade
|
| Other Investing Activities | 21,451 | 17,334 | 22,412 | 171.14 | 376.76 | Upgrade
|
| Investing Cash Flow | -81,859 | -267,211 | 103,301 | -38,619 | 177,660 | Upgrade
|
| Long-Term Debt Issued | 688,461 | 262,560 | 190,195 | 2,500 | 174,817 | Upgrade
|
| Total Debt Issued | 688,461 | 262,560 | 190,195 | 2,500 | 174,817 | Upgrade
|
| Long-Term Debt Repaid | -526,208 | -214,458 | -140,453 | -18,389 | -521,173 | Upgrade
|
| Total Debt Repaid | -526,208 | -214,458 | -140,453 | -18,389 | -521,173 | Upgrade
|
| Net Debt Issued (Repaid) | 162,253 | 48,102 | 49,742 | -15,889 | -346,356 | Upgrade
|
| Issuance of Common Stock | 37,000 | - | - | - | - | Upgrade
|
| Financing Cash Flow | 199,253 | 48,102 | 49,742 | -15,889 | -346,356 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | -0.07 | Upgrade
|
| Net Cash Flow | 9,656 | -133,355 | 146,569 | 21,618 | -487,720 | Upgrade
|
| Free Cash Flow | -368,358 | 69,159 | -49,837 | 33,540 | -327,834 | Upgrade
|
| Free Cash Flow Margin | -48.26% | 11.31% | -8.65% | 6.72% | -64.62% | Upgrade
|
| Free Cash Flow Per Share | -3275.34 | 614.75 | -442.99 | 298.13 | -2914.07 | Upgrade
|
| Cash Interest Paid | 14,381 | 5,417 | 5,212 | 4,763 | 17,059 | Upgrade
|
| Cash Income Tax Paid | 15,656 | 4,765 | - | 33,805 | 29,761 | Upgrade
|
| Levered Free Cash Flow | -368,870 | -73,981 | - | 100,710 | 199,243 | Upgrade
|
| Unlevered Free Cash Flow | -359,694 | -70,582 | - | 103,584 | 209,539 | Upgrade
|
| Change in Working Capital | -175,417 | 13,556 | -86,636 | 36,412 | -369,185 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.